Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jun 2017 for Knight Therapeutics Inc., €4,901.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Jeffrey Lorne Kadanoff: trading record in brief
This profile gathers the share dealings of Jeffrey Lorne Kadanoff in Knight Therapeutics Inc. In total, 8 filings cover trades dated from 15 March 2016 to 15 June 2017.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 20 June 2017 with a share grant (€4,901) in Knight Therapeutics Inc. Filings reach the SEDI feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Lorne Kadanoff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
737 shares@ CA$9.8353.4% of flowCommon SharesTSXSEDI:3023718
589 shares@ CA$10.3746.6% of flowCommon SharesTSXSEDI:2979065
644 shares@ CA$9.972.9% of flowCommon SharesTSXSEDI:2932244
10,000 shares@ CA$10.0044.4% of flowCommon SharesTSXSEDI:2932247
404 shares@ CA$9.001.5% of flowCommon SharesTSXSEDI:2893908
425 shares@ CA$8.561.6% of flowCommon SharesTSXSEDI:2853937
12,500 shares@ CA$8.0042.6% of flowCommon SharesTSXSEDI:2846072
415 shares@ CA$7.511.3% of flowCommon SharesTSXSEDI:2812801
8 of 8 declarations
